David B. Rein

Rebecca L Morgan, Bryce D Smith, Yngve Falck-Ytter, 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Medical Care Expenditures for Genital Herpes in the United States

D. Rein, David B. Rein, G. Tao, 2000, Sexually transmitted diseases.

Characteristics and Geographic Dispersion of Syndromic Surveillance Systems in the United States in 2008

David B. Rein, L. Smith, Sarah B. Lesesne, 2011 .

The global burden of hepatitis E virus genotypes 1 and 2 in 2005

Gretchen A. Stevens, G. Stevens, S. Wiersma, 2012, Hepatology.

Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States

L. Finelli, B. Bell, D. Rein, 2007, Pediatrics.

Cost-Effectiveness of Glaucoma Interventions in Barbados and Ghana

D. Rein, J. Wittenborn, David B. Rein, 2011, Optometry and vision science : official publication of the American Academy of Optometry.

Vision problems are a leading source of modifiable health expenditures.

D. Rein, David B. Rein, 2013, Investigative ophthalmology & visual science.

Do enrollees in 'look-alike' Medicaid and SCHIP programs really look alike? State Children's Health Insurance Program.

J. Bronstein, J. Edwards, David B. Rein, 2002, Health affairs.

Community‐based hepatitis B screening programs in the United States in 2008

D. Rein, C. Weinbaum, David B. Rein, 2010, Journal of viral hepatitis.

A matter of classes: stratifying health care populations to produce better estimates of inpatient costs.

D. Rein, David B. Rein, 2005, Health services research.

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

D. Rein, Bryce D. Smith, C. Weinbaum, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage.

D. Rein, J. Hersey, A. Honeycutt, 2006, American journal of public health.

The Costs and Impacts of Testing for Hepatitis C Virus Antibody in Public STD Clinics

T. S. Jones, D. Rein, Olga A. Khavjou, 2007, Public health reports.

Association Between Social Determinants of Health and Examination-Based Vision Loss vs Self-reported Vision Measures.

J. Saaddine, D. Rein, J. Wittenborn, 2023, JAMA ophthalmology.

An Electronic Health Record–based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial

Mark Singer, D. Rein, Bryce D. Smith, 2017, Medical care.

An Electronic Health Record–based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965

Mark Singer, D. Rein, Bryce D. Smith, 2017 .

Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.

D. Nerenz, D. Rein, Jenni M. Wise, 2018, The American journal of managed care.

Hepatitis C virus testing for case identification in persons born during 1945‐1965: Results from three randomized controlled trials

D. Nerenz, D. Rein, Bryce D. Smith, 2018, Hepatology.

Implementation of Birth-Cohort Testing for Hepatitis C Virus

D. Rein, Bryce D. Smith, K. Brown, 2017, Health promotion practice.

Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST‐C study

D. Nerenz, D. Rein, Bryce D. Smith, 2017, Hepatology.

Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study.

D. Rein, M. Fallon, Bryce D. Smith, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.

J. Ward, D. Rein, Bryce D. Smith, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.

D. Rein, C. Weinbaum, David B. Rein, 2008, Vaccine.

High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin

Jessica S. Rogers-Brown, W. Thompson, D. Rein, 2022, Substance use & misuse.

The Economic Costs and Benefits of Dog Guides for the Blind

Kathleen E Wirth, D. Rein, K. Wirth, 2008, Ophthalmic epidemiology.

Data to guide the "test and treat era" of hepatitis C.

J. Ward, D. Rein, Bryce D. Smith, 2012, Gastroenterology.

Settings Hepatitis C Virus Testing Perspectives Among Primary Care Physicians in Four Large Primary Care

D. Rein, Jen-Jung Pan, Bryce D. Smith, 2014 .

New HIV cases attributable to syphilis in the USA: estimates from a simplified transmission model.

D. Rein, S. Pinkerton, K. Irwin, 1999, AIDS.

P703 THE GLOBAL BURDEN OF HEPATITIS A VIRUS IN 1990 AND 2005

Gretchen A. Stevens, A. Flaxman, S. Wiersma, 2014 .

Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008

D. Rein, C. Weinbaum, David B. Rein, 2010, Hepatology.

Prevalence of Diabetic Retinopathy in the US in 2021.

Aaron Y. Lee, A. Flaxman, J. Saaddine, 2023, JAMA ophthalmology.

Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries.

E. Chew, J. Saaddine, D. Rein, 2022, JAMA ophthalmology.

Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.

Noele P. Nelson, D. Rein, N. Nelson, 2016, Vaccine.

The potential cost-effectiveness of amblyopia screening programs.

J. Saaddine, D. Rein, Xinzhi Zhang, 2012, Journal of pediatric ophthalmology and strabismus.

The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics

J. Wittenborn, David B. Rein, D. Liffmann, 2016, Hepatology.

Prevalence of Visual Acuity Loss or Blindness in the US

A. Flaxman, J. Saaddine, D. Rein, 2021, JAMA ophthalmology.

A refined estimate of the lifetime cost of pelvic inflammatory disease.

D. Rein, T. Gift, David B. Rein, 2004, Sexually transmitted diseases.

THE ECONOMIC BURDEN OF VISION LOSS AND BLINDNESS IN THE UNITED STATES.

J. Saaddine, D. Rein, Ping Zhang, 2021, Ophthalmology.

The cost of visual impairment: purposes, perspectives, and guidance.

H. Taylor, D. Matchar, Paul P. Lee, 2010, Investigative ophthalmology & visual science.

Technical appendix: cost-effectiveness of vitamin therapy for age-related macular degeneration.

Stephen W. Sorensen, J. Saaddine, T. Clemons, 2007, Ophthalmology.

The Prevalence of Diagnosis of Major Eye Diseases and their Associated Payments in the Medicare Fee-for-Service Program

J. Saaddine, D. Rein, Ping Zhang, 2021, Ophthalmic epidemiology.

Should Patient Characteristics Be Included in a Severity of Need Index for Ryan White Program, Part A Services? An Evaluation Based on the Medical Expenditure Panel Survey

J. Segel, David B. Rein, 2007 .

Models of Community-Based Hepatitis B Surface Antigen Screening Programs in the U.S. and Their Estimated Outcomes and Costs

D. Rein, Bryce D. Smith, C. Weinbaum, 2011, Public health reports.